FBIO
Price
$1.74
Change
-$0.01 (-0.57%)
Updated
Feb 23, 6:59 PM EST
32 days until earnings call
FBRX
Price
$0.69
Change
-$0.01 (-1.43%)
Updated
Feb 23, 6:59 PM EST
25 days until earnings call
Ad is loading...

Compare trend and price FBIO vs FBRX

Header iconFBIO vs FBRX Comparison
Open Charts FBIO vs FBRXBanner chart's image
Fortress Biotech
Price$1.74
Change-$0.01 (-0.57%)
Volume$62.81K
CapitalizationN/A
Forte Biosciences
Price$0.69
Change-$0.01 (-1.43%)
Volume$10.22K
CapitalizationN/A
View a ticker or compare two or three
FBIO vs FBRX Comparison Chart

Loading...

FBIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
FBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FBIO vs. FBRX commentary
Feb 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIO is a Hold and FBRX is a StrongBuy.

COMPARISON
Comparison
Feb 25, 2024
Stock price -- (FBIO: $1.74 vs. FBRX: $0.69)
Brand notoriety: FBIO and FBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIO: 18% vs. FBRX: 45%
Market capitalization -- FBIO: $31.98M vs. FBRX: $25.07M
FBIO [@Biotechnology] is valued at $31.98M. FBRX’s [@Biotechnology] market capitalization is $25.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIO’s FA Score shows that 1 FA rating(s) are green whileFBRX’s FA Score has 0 green FA rating(s).

  • FBIO’s FA Score: 1 green, 4 red.
  • FBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, FBRX is a better buy in the long-term than FBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIO’s TA Score shows that 4 TA indicator(s) are bullish while FBRX’s TA Score has 5 bullish TA indicator(s).

  • FBIO’s TA Score: 4 bullish, 3 bearish.
  • FBRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FBIO is a better buy in the short-term than FBRX.

Price Growth

FBIO (@Biotechnology) experienced а -6.45% price change this week, while FBRX (@Biotechnology) price change was -0.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

FBIO is expected to report earnings on Mar 27, 2024.

FBRX is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FBIO with price predictions.
OPEN
A.I.dvisor published
a Summary for FBRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FBIO($32M) has a higher market cap than FBRX($25.1M). FBRX YTD gains are higher at: -16.028 vs. FBIO (-42.193). FBRX has higher annual earnings (EBITDA): -31.04M vs. FBIO (-159.65M). FBIO has more cash in the bank: 72.3M vs. FBRX (46.2M). FBIO has higher revenues than FBRX: FBIO (81M) vs FBRX (0).
FBIOFBRXFBIO / FBRX
Capitalization32M25.1M127%
EBITDA-159.65M-31.04M514%
Gain YTD-42.193-16.028263%
P/E RatioN/A0.58-
Revenue81M0-
Total Cash72.3M46.2M156%
Total Debt70.1MN/A-
FUNDAMENTALS RATINGS
FBIO vs FBRX: Fundamental Ratings
FBIO
FBRX
OUTLOOK RATING
1..100
5011
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9348
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (28) in the Biotechnology industry is significantly better than the same rating for FBRX (98) in the null industry. This means that FBIO’s stock grew significantly faster than FBRX’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FBRX (100) in the null industry. This means that FBIO’s stock grew similarly to FBRX’s over the last 12 months.

FBIO's SMR Rating (99) in the Biotechnology industry is in the same range as FBRX (100) in the null industry. This means that FBIO’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's Price Growth Rating (48) in the null industry is somewhat better than the same rating for FBIO (93) in the Biotechnology industry. This means that FBRX’s stock grew somewhat faster than FBIO’s over the last 12 months.

FBRX's P/E Growth Rating (54) in the null industry is somewhat better than the same rating for FBIO (100) in the Biotechnology industry. This means that FBRX’s stock grew somewhat faster than FBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOFBRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 10 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
FBIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
FBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPTX6.340.08
+1.28%
Repare Therapeutics
CCI108.690.72
+0.67%
Crown Castle
WU12.960.01
+0.08%
Western Union Company (The)
BVH75.00N/A
N/A
Bluegreen Vacations Holding Corp
INKT0.90-0.03
-2.93%
MiNK Therapeutics

FBRX and

Correlation & Price change

A.I.dvisor tells us that FBRX and NVIVQ have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBRX and NVIVQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
+4.39%
NVIVQ - FBRX
32%
Poorly correlated
+2.00%
CRIS - FBRX
31%
Poorly correlated
-3.26%
FBIO - FBRX
31%
Poorly correlated
-0.57%
AXON - FBRX
31%
Poorly correlated
-0.34%
EIGR - FBRX
28%
Poorly correlated
-6.72%
More